BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Search

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
8/27/15 Amgen (AMGN) Repatha for Dyslipidemia / Hypercholesterolemia Subscribers Only Subscribers Only Subscribers Only
8/27/15 Boehringer Ingelheim Synjardy for Diabetes Mellitus, Type II Subscribers Only Subscribers Only Subscribers Only
8/27/15 Symbiomix Therapeutics SYM-1219 for Urinary Tract and Reproductive Tract Infections (Antibacterial) Subscribers Only Subscribers Only Subscribers Only
8/27/15 ProMetic (PLI:CN) PBI-4050 for Diabetes Mellitus, Type II Subscribers Only Subscribers Only Subscribers Only
8/26/15 Verastem, Inc. (VSTM) Defactinib for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
08/28/15 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
08/29/15 Subscribers Only Subscribers Only Patent - Expiration of 30-Month Stay
08/30/15 Subscribers Only Subscribers Only Trial Data - Other
08/30/15 Subscribers Only Subscribers Only Trial Data - Top-Line Results
08/30/15 Subscribers Only Subscribers Only Trial Data - Updated Results